Yen Ting Chen
Scripps Research Institute
27 Papers
204 Citations
Yen Ting Chen is an academic researcher from Scripps Research Institute. The author has contributed to research in topics: Rho-associated protein kinase & Proteases. The author has an hindex of 16, co-authored 25 publications. Previous affiliations of Yen Ting Chen include Scripps Health.
Chat about Author
Papers
Patent
Bicyclic heteroaryls as kinase inhibitors
Yangbo Feng,Yen Ting Chen,Hampton Sessions,Jitendra Kumar Mishra,Sarwat Chowdhury,Yan Yin,Philip LoGrasso,Jun-Li Luo,Thomas D. Bannister,Thomas Schroeter +9 more
- 22 Oct 2010
TL;DR: In this article, a heteroaryl compound having inhibitory bioactivity with respect to a Rho kinase, an AKT kinase or a p70S6K kinase was presented.
85
Use of recombinant Entamoeba histolytica cysteine proteinase 1 to identify a potent inhibitor of amebic invasion in a human colonic model
Samuel G. Meléndez-López,Scott Herdman,Ken Hirata,Min-Ho Choi,Youngchool Choe,Charles S. Craik,Conor R. Caffrey,Elisabeth Hansell,Bibiana Chávez-Munguía,Yen Ting Chen,William R. Roush,James H. McKerrow,Lars Eckmann,Jianhua Guo,Samuel L. Stanley,Sharon L. Reed +15 more
TL;DR: The effect of the vinyl sulfone cysteine proteinase inhibitors K11777 and WRR483 on invasion of human colonic xenografts strongly suggests a significant role of secreted amebic proteinases, such as EhCP1, in the pathogenesis of amebiasis.
Optimization of a Series of Mu Opioid Receptor (MOR) Agonists with High G Protein Signaling Bias
Nicole M. Kennedy,Cullen L. Schmid,Nicolette C. Ross,Kimberly M. Lovell,Zhizhou Yue,Yen Ting Chen,Michael D. Cameron,Laura M. Bohn,Thomas D. Bannister +8 more
TL;DR: The synthesis and optimization of piperidine benzimidazolone MOR agonists that together display a wide range of bias (G/βarr2) are described and structural features affecting potency and maximizing bias are identified and it is shown that many compounds have desirable properties, such as long half-lives and high brain penetration.
Chroman-3-amides as potent Rho kinase inhibitors
Yen Ting Chen,Thomas D. Bannister,Amiee Weiser,Evelyn Griffin,Li Lin,Claudia Ruiz,Michael D. Cameron,Stephan C. Schürer,Derek R. Duckett,Thomas Schröter,Philip LoGrasso,Yangbo Feng +11 more
TL;DR: Ch chroman-3-amides are reported as highly potent ROCK inhibitors with sufficient kinase selectivity, excellent cell activity, good microsomal stability, and desirable pharmacokinetic properties for study as potential therapeutic agents.
52
Synthesis of macrocyclic trypanosomal cysteine protease inhibitors
Yen Ting Chen,Ricardo Lira,Ricardo Lira,Elizabeth Hansell,James H. McKerrow,William R. Roush,William R. Roush +6 more
TL;DR: The binding mode of K11002 to cruzain, the major cysteine protease of Trypanosoma cruzi was used in the design of conformationally constrained inhibitors, and Vinyl sulfone-containing macrocycles were synthesized via olefin ring-closing metathesis and evaluated against Cruzain and the closely related cysteined protease, rhodesain.
46